2-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide

2-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide Struktur
2304623-37-6
CAS-Nr.
2304623-37-6
Englisch Name:
2-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide
Synonyma:
Parecoxib Sodium Impurity 59;2-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide
CBNumber:
CB84676614
Summenformel:
C16H14N2O3S
Molgewicht:
314.35896
MOL-Datei:
2304623-37-6.mol

2-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide Eigenschaften

Sicherheit

2-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide Chemische Eigenschaften,Einsatz,Produktion Methoden

2-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


2-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 23)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hangzhou Huarong Pharm Co., Ltd.
571-86758373 +8613588754946
sales@huarongpharm.com CHINA 3149 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-52878169 15701683040
sales@bjcomparison.com China 4693 58
Nanjing Norris-Pharm Technology Co., Ltd 13901585132
799750417@qq.com China 8888 55
ChemStrong Scientific Co.,Ltd 0755-0755-66853366 13670046396
sales@chem-strong.com China 17994 56
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
greensnown@163.com China 9911 50
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 7933 55
Shanghai Akasaka Biotechnology Co., Ltd. 15121162054
CHINA 635 58
Wuxi Helen Biotechnology Co., Ltd., 0510-85629785 18013409632
sales@reading-chemicals.com China 14092 58
Hubei Xinyang Medical Technology Co., Ltd 15347293736 15347293736
2853117764@qq.com China 8695 58

  • 2-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide
  • Parecoxib Sodium Impurity 59
  • 2304623-37-6
  • 304623-37-6
Copyright 2019 © ChemicalBook. All rights reserved